William Polvino

Director/Board Member at SAB BIOTHERAPEUTICS, INC.

Net worth: - $ as of 2024-08-30

63 year

44 connections

Health Technology

Consumer Services

Finance

Profile

William J.
Polvino is currently the Chief Executive Officer & Director at Bridge Medicines LLC since 2017.
He is also the Director at SAB Sciences, Inc. since 2019 and the Independent Director at SAB Biotherapeutics, Inc. since 2021.
Previously, Dr. Polvino served as the President & Chief Executive Officer at Sapphire Therapeutics, Inc. from 2002 to 2009 and at Veloxis Pharmaceuticals A from 2011 to 2015.
He also held positions at Helsinn Therapeutics (U.S.), Inc., Big Cypress Acquisition Corp., Merck & Co., Inc., and Innoviva, Inc.Dr. Polvino holds a doctorate degree from the University of Medicine & Dentistry of New Jersey and an undergraduate degree from Boston College.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SAB BIOTHERAPEUTICS, INC. -.--%	2024-07-14	0 ( -.--% )	- $	2024-08-30

Latest news about William Polvino

SAB BIOTHERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	22-07-11	AQ
SAB Biotherapeutics : Amendment to Statement of Changes in Beneficial Ownership (Form 4/A)	21-11-22	PU
SAB BIOTHERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Changes in Registrant's Certifying Accountant, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Change in Shell Company Status, Financial Statements and Exhibits (form 8-K)	21-10-28	AQ
BIG CYPRESS ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders (form 8-K)	21-10-21	AQ
Big Cypress Acquisition Corp. Announces Board Changes	21-10-21	CI

William Polvino active positions

Companies	Position	Start
SAB BIOTHERAPEUTICS, INC.	Director/Board Member	2021-10-21
Bridge Medicines LLC Bridge Medicines LLC Pharmaceuticals: MajorHealth Technology Bridge Medicines LLC operates as a drug discovery company. It provides spanning therapeutic areas including infectious disease, oncology, neuropsychiatry, and rare diseases. The company was founded on November 1, 2016 and is headquartered in New York, NY.	Chief Executive Officer	2017-03-26
SAB Sciences, Inc. SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million.	Director/Board Member	2018-12-31

All active positions of William Polvino

Former positions of William Polvino

Companies	Position	End
VELOXIS PHARMACEUTICALS A/S	Chief Executive Officer	2015-12-09
Sapphire Therapeutics, Inc. Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ.	President	2008-12-31
BIG CYPR	Director/Board Member	-
Helsinn Therapeutics (U.S.), Inc. Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ.	Chief Executive Officer	-
MERCK & CO., INC.	Corporate Officer/Principal	-

See the detail of William Polvino's experience

Training of William Polvino

University of Medicine & Dentistry of New Jersey	Doctorate Degree
Boston College	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of William Polvino's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
INNOVIVA, INC.	Health Technology
MERCK & CO., INC.	Health Technology
SAB BIOTHERAPEUTICS, INC.	Health Technology

Private companies	6
Sapphire Therapeutics, Inc. Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ.	Health Technology
Veloxis Pharmaceuticals A/S Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark.	Health Technology
Helsinn Therapeutics (U.S.), Inc. Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ.	Health Technology
Bridge Medicines LLC Bridge Medicines LLC Pharmaceuticals: MajorHealth Technology Bridge Medicines LLC operates as a drug discovery company. It provides spanning therapeutic areas including infectious disease, oncology, neuropsychiatry, and rare diseases. The company was founded on November 1, 2016 and is headquartered in New York, NY.	Health Technology
SAB Sciences, Inc. SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million.	Health Technology
Big Cypress Acquisition Corp. Big Cypress Acquisition Corp. Financial ConglomeratesFinance Big Cypress Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on November 12, 2020 and is headquartered in Miami Beach, FL.	Finance